Want to see DOCS full AI Analyst Report?
DOCS Stock Chart & Stats
$24.74
-$0.03(-0.15%)
At close: 4:00 PM EDT
$24.74
-$0.03(-0.15%)
Day’s Range― - ―
52-Week Range$17.15 - $76.51
Previous Close$20.42
Volume2.18M
Average Volume (3M)6.19M
Market Cap
$4.83B
Enterprise Value$3.29K
Total Cash (Recent Filing)$687.79M
Total Debt (Recent Filing)$9.67M
Price to Earnings (P/E)29.6
Beta1.73
Next Earnings
Nov 05, 2026EPS Estimate
0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.89
Shares Outstanding127,349,365
10 Day Avg. Volume2,365,679
30 Day Avg. Volume6,186,325
Financial Highlights & Ratios
PEG Ratio-1.89
Price to Book (P/B)4.58
Price to Sales (P/S)6.76
P/FCF Ratio13.72
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$31.64Price Target Upside27.90% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
EPS Forecast (FY)1.35
Revenue Forecast (FY)$676.33M
Bulls Say, Bears Say
Bulls Say
High-margin, Cash-generative ModelDoximity combines strong operating margins with cash conversion closely aligned to earnings. This scalable model can fund product investment and shareholder returns while reducing reliance on external financing.
Very Low Financial LeverageMinimal debt and substantial liquidity provide resilience through uncertain healthcare spending cycles. The balance sheet also gives Doximity flexibility to invest in AI, pursue opportunities and repurchase shares.
Verified Network And AI Enterprise TractionGrowth in clinician usage and health-system contracts strengthens Doximity’s network effects and enterprise position. Verified content controls and physician adoption may support durable AI monetization and customer retention.
Bears Say
Revenue Growth Is DeceleratingThe business remains profitable, but slower growth raises the importance of successful AI monetization and customer expansion. A lower growth base could constrain operating leverage and reduce the pace of long-term earnings compounding.
AI Investment Pressures MarginsAI compute costs are being recorded largely in cost of revenue, creating a structural risk that greater product usage does not translate proportionally into profit. Sustained investment may keep margins below prior peaks.
Healthcare Budget And AI Adoption BarriersDoximity’s expansion depends on healthcare and life-sciences customers approving new budgets and accepting clinical AI risk. Procurement, privacy and liability reviews could lengthen sales cycles and delay broader adoption.
Doximity News
DOCS FAQ
What was Doximity’s price range in the past 12 months?
Doximity lowest stock price was $17.15 and its highest was $76.51 in the past 12 months.
What is Doximity’s market cap?
Doximity’s market cap is $4.83B.
When is Doximity’s upcoming earnings report date?
Doximity’s upcoming earnings report date is Nov 05, 2026 which is in 61 days.
How were Doximity’s earnings last quarter?
Doximity released its earnings results on Aug 06, 2026. The company reported $0.29 earnings per share for the quarter, missing the consensus estimate of $0.303 by -$0.013.
Is Doximity overvalued?
According to Wall Street analysts Doximity’s price is currently Undervalued.
Does Doximity pay dividends?
Doximity does not currently pay dividends.
What is Doximity’s EPS estimate?
Doximity’s EPS estimate is 0.34.
How many shares outstanding does Doximity have?
Doximity has 127,349,365 shares outstanding.
What happened to Doximity’s price movement after its last earnings report?
Doximity reported an EPS of $0.29 in its last earnings report, missing expectations of $0.303. Following the earnings report the stock price went up 32.623%.
Which hedge fund is a major shareholder of Doximity?
Currently, no hedge funds are holding shares in DOCS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Doximity Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$31.64 (27.90% Upside)
$31.64 (27.90% Upside)
Blogger Sentiment
Neutral
DOCS Sentiment 59%
Sector Average 60%
Sector Average 60%
Hedge Fund Trend
Decreased
By 203.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.4%
Last 30 Days <0.1%
Last 30 Days <0.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.54%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-10.01%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Doximity
Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.
DOCS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call combined strong financial and operational positives — revenue and adjusted EBITDA beats, raised full‑year guidance, robust cash balance, aggressive share repurchases, independent validation of Doximity Ask, rapid clinician adoption and meaningful enterprise wins — with managed near‑term tradeoffs driven by deliberate AI investment. Short‑term impacts include lower gross margin from compute spend, higher OpEx and a cautious Q2 growth comp, but management positioned these as intentional investments to capture a large long‑term AI opportunity while preserving high margins. Overall the positives (beat, guidance raise, product validation, adoption and balance sheet strength) outweigh the near‑term headwinds tied to investment cadence and timing of AI monetization.View all DOCS earnings summariesDOCS Revenue Breakdown
93.00% Subscription
7.00% Other
DOCS Stock 12 Month Forecast
Average Price Target
$31.64
▲(27.90% Upside)
Technical Analysis
Ownership Overview
3.48% Insiders
26.74% Mutual Funds
12.63% Other Institutional Investors
33.77% Public Companies and Individual Investors